Skip to main content

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

deliver robust, reproducible solutions for sample preparation enabling a new era of end-to-end standardization in proteomics

Brought to you byEvosep
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

Evosep, a global leader in proteomics solutions, is proud to announce a new initiative at HUPO 2025 aimed at solving one of LCMS based proteomics most persistent challenges: sample preparation. Building on its legacy of standardizing proteomics LC separation, Evosep is now expanding upstream to deliver robust, and reproducible solutions for sample preparation enabling a new era of end-to-end standardization in proteomics.

What to Expect

  • Evotip based Standardized Kits: Designed for reproducibility and minimal manual handling.
  • Reference Protocols: Harmonized methods for consistent results across labs.
  • Evosep Sample Preparation System: Designed for efficient and robust standardized sample handling and processing.
  • Transparent Development: Regular updates and open documentation throughout 2026.

Proteomics is advancing rapidly, driven by technological breakthroughs and the demand for deeper biological insights. Yet as studies grow in scale and complexity, the bottleneck has shifted from instrumentation to sample preparation and workflow integration. Researchers and biologists across industries are looking for standardized, cost effective, and automation-ready solutions that minimize manual steps and maximize reproducibility.

By integrating reference protocols, miniaturized, standardized kits, and harmonized methods from the very first step, Evosep will deliver greater consistency, reliability, and efficiency across the entire proteomics workflow.

Integrating proteomics workflows around the Evotip enables fully automated, high-throughput sample preparation, eliminating manual steps. This approach ensures robust and reproducible processing of thousands of samples, delivering high sensitivity, tight retention time stability, and accurate quantification across a wide dynamic range. This will result is greater efficiency, reduced variability, and scalable, cost-effective proteomics studies with clinical-grade data quality.


“LCMS-based proteomics is at a turning point. By addressing the bottleneck in sample preparation and delivering true end-to-end standardization, we will enable researchers to scale their science and collaborate without compromising quality. With our integrated workflows, Evosep is making proteomics more accessible, reproducible, and ready for automation—so scientists can focus on results, not technology..” - Morten Bern, CEO of Evosep

Evosep’s new Open Innovation Initiative brings together selected leading proteomics scientists to co-develop and validate sample preparation kits and protocols. This collaborative effort ensures that solutions are not only scientifically rigorous but also practical and scalable across diverse research environments and applied life science.

In line with Evosep’s commitment to transparency, the development journey will be shared openly with the broader community—through technical updates, publications, and public documentation.

Evosep invites the global proteomics community to follow the development of these solutions and stay informed as the initiative unfolds. Updates will be shared via https://www.evosep.com, newsletters, and webinars. While participation is limited to partners, the resulting protocols and kits will be made broadly available to support the next wave of breakthroughs in proteomics.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo